Newsroom
Sorted by: Latest
-
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions
FRANKFURT, Germany--(BUSINESS WIRE)--Regnology to acquire Moody’s Regulatory Reporting & ALM Solutions, boosting global reach and innovation in financial compliance....
-
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year
TURIN, Italy--(BUSINESS WIRE)--Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. The Azure Expert MSP program is designed by Micro...
-
Reply riconosciuta come Microsoft Azure Expert Managed Services Provider per il sesto anno consecutivo
TORINO, Italia--(BUSINESS WIRE)--Reply [EXM, STAR: REY] annuncia di essere stata nuovamente riconosciuta come Microsoft Azure Expert Managed Services Provider (MSP). Il riconoscimento conferma la solida esperienza di Reply e la costante affidabilità nel fornire soluzioni e servizi cloud di alta qualità sulla piattaforma Microsoft Azure, grazie all’expertise tecnica delle sue società specializzate – Cluster Reply, Solidsoft Reply e Valorem Reply. Il programma Azure Expert MSP è stato ideato da M...
-
Reply erneut als „Microsoft Azure Expert Managed Services Provider” ausgezeichnet – zum sechsten Mal in Folge
TURIN, Italien--(BUSINESS WIRE)--Reply [EXM, STAR: REY] wurde zum sechsten Mal in Folge als „Microsoft Azure Expert Managed Services Provider” (MSP) anerkannt. Mit dieser Auszeichnung bestätigt Microsoft die ausgewiesene Expertise von Reply sowie die kontinuierlich erfolgreiche Umsetzung hochwertiger Cloud-Lösungen und Services auf der Microsoft-Azure-Plattform. Dahinter steht das tiefe technische Know-how der Reply Unternehmen Cluster Reply, Solidsoft Reply und Valorem Reply. Mit dem „Expert M...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100® Moderate Buffer UCITS ETF - March 17.12.2025 QMAR.LN IE0006S0EBF2 100,002.00 USD 2,250,577.04 22.505 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 17.12.2025 FTAI IE000YIQZ0H6 100,002.00 USD 2,264,076.67 22.640 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 17.12.2025 MJUN LN IE000CO3P697 150,002.00 USD 3,697,745.84 24.651 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 17.12.2025 QDEC.LN IE000GAKWFA7 100,002.00 USD 2,267,809.34 22.678 ...
-
HCA Healthcare UK Goes On “The Cloud” with MEDITECH Expanse EHR, Powering Patient-Centred Care
CANTON, Mass.--(BUSINESS WIRE)--Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and improving workflow efficiencies. The innovative, cloud-based EHR provides clinicians across all facilities with a unified, multi-disciplinary health record, giving them a seamless view of the patient's journey and health status whenever and wherever the patient receives c...
-
Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate Programs to Treat Serious Diseases
BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced that it secured 145 billion KRW (approximately US$100 million) in convertible preferred stock investments. This round is led by returning investor KB Investment and includes other existing investors, IMM Investment, Woori Venture Partners and Stassets Investment. New investors includ...